Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02288247 |
|---|---|
| Brief Title: | A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone (PRESIDE) |
| First Submitted : | November 7, 2014 |
| First Submitted that Met QC Criteria : | November 7, 2014 |
| First Posted : | November 11, 2014 (Estimate) |
| Results First Submitted : | September 29, 2021 |
| Results First Submitted that Met QC Criteria : | November 17, 2021 |
| Results First Posted : | December 15, 2021 |
| Certification/Extension First Submitted : | April 29, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | April 29, 2021 |
| Certification/Extension First Posted : | May 3, 2021 |
| Last Update Submitted that Met QC Criteria : | April 4, 2024 |
| Last Update Posted : | April 5, 2024 |